My watch list
my.bionity.com  
Login  

209 Current news from israel

rss
matching the following criteria

Genmab Enters Commercial DuoBody Technology Agreement with BioNovion in the Field of Immuno-Oncology

23-Feb-2015

Genmab A/S announced it has entered a co-development and commercialization agreement with BioNovion to evaluate a number of DuoBody product candidates targeting immune checkpoints. Genmab and BioNovion will contribute panels of antibodies for the creation of bispecific antibody products using ...

more

Genmab Announces Preliminary Results in Phase II Study of Daratumumab in Double Refractory Multiple Myeloma

05-Feb-2015

Genmab A/S announced preliminary results from the Phase II study of daratumumab in double refractory multiple myeloma conducted by its collaboration partner Janssen Biotech, Inc. (Janssen). The overall response rate (ORR) in the study was 29.2% in the 16 mg/kg dosing group and the median ...

more

Ascendis Pharma A/S Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil

16-Jan-2015

Ascendis Pharma A/S announced that it has initiated a Phase 1 single ascending dose study of TransCon Treprostinil in healthy volunteers. TransCon Treprostinil is being developed to treat pulmonary arterial hypertension, a life-threatening orphan disease characterized by elevated blood pressure ...

more

CMC Biologics and OncoSynergy Enter into an Agreement for Accelerated Process Development of an Investigational Drug to Combat Ebola

Experimental monoclonal antibody to be used in clinical trials with patients in West Africa infected with the Ebola virus

18-Dec-2014

CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of ...

more

image description
Fat cells reprogrammed to increase fat burning

16-Dec-2014

White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern ...

more

Genmab Announces Phase II Study of Daratumumab in Non-Hodgkin’s Lymphomas

05-Dec-2014

Genmab A/S announced that its collaboration partner, Janssen Biotech, Inc. (Janssen) plans to start a Phase II study of daratumumab in non-Hodgkin’s lymphomas (NHL). The study (LYM2001) will evaluate daratumumab monotherapy in three different types of NHL, diffuse large B-cell lymphoma (DLBCL), ...

more

New enzyme technology converts waste oils into biodiesel

04-Dec-2014

Novozymes announced the launch of Novozymes Eversa®, the first commercially available enzymatic solution to make biodiesel from waste oils. The enzymatic process converts used cooking oil or other lower grade oils into biodiesel. Biodiesel producers can thereby reduce their raw material costs. ...

more

Contera Pharma announces acquisition by Korean Bukwang Pharmaceutical

JM-010 to enter global development for L-DOPA induced dyskinesia

03-Dec-2014

Contera Pharma announced that Bukwang Pharmaceutical has acquired 100% of Contera Pharma from its current shareholders. The shareholders received an undisclosed upfront payment and are entitled to future contingent and royalty payments. Contera Pharma was founded by John Bondo Hansen and Mikael ...

more

New guide to the genetic jungle of muscles can help health research

28-Nov-2014

New guide to the genetic jungle of muscles can help health research Researchers from Aarhus University and Bispebjerg Hospital have created a comprehensive overview of how tens of thousands of genes interact in relation to the behavior of muscles. At the same time, they have developed a guide to ...

more

Genmab Announces New Phase III Combination Study of Daratumumab in Frontline Multiple Myeloma

12-Nov-2014

Genmab A/S announced that the French Intergroup of Myeloma (IFM) in collaboration with Dutch-Belgian Cooperative Trial Group for Hematology Oncology (HOVON) and Janssen Biotech, Inc. (Janssen) plans to start an additional Phase III study of daratumumab in frontline multiple myeloma. The study ...

more

Page 1 From 21
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE